PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.46%
Net income growth under 50% of MCHP's 19.88%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
0.45%
Some D&A expansion while MCHP is negative at -4.13%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-116.67%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
9.30%
SBC growth while MCHP is negative at -55.92%. John Neff would see competitor possibly controlling share issuance more tightly.
-1385.71%
Negative yoy working capital usage while MCHP is 88.66%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-260.90%
Both yoy AR lines negative, with MCHP at -118.73%. Martin Whitman would suspect an overall sector lean approach or softer demand.
13.95%
Inventory shrinking or stable vs. MCHP's 158.23%, indicating lean supply management. David Dodd would confirm no demand shortfall.
No Data
No Data available this quarter, please select a different quarter.
317.86%
Growth well above MCHP's 68.56%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-100.00%
Negative yoy while MCHP is 426.87%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-29.07%
Negative yoy CFO while MCHP is 161.01%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
49.77%
CapEx growth well above MCHP's 64.39%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
28.02%
Less growth in investment purchases vs. MCHP's 92.33%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
24.03%
We have some liquidation growth while MCHP is negative at -88.15%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
92.17%
Investing outflow well above MCHP's 10.92%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both yoy lines negative, with MCHP at -92.32%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-43.18%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.